[Aojing Medical: Unable to disclose the 2026 third quarter report as scheduled] On October 30, Aojing Medical (688613.SH) announced that the company was originally scheduled to disclose the third quarter report on October 31, 2026. Due to the heavy workload of data accounting, relevant self-examination and verification and financial data impact calculation have not yet been completed, and it is expected to be unable to be disclosed within the legal period. The company needs to review the financial data of the previous period, which may involve the correction of accounting errors in the previous period, resulting in delays in the preparation and review work. The company has extended the disclosure time to December 31, 2026, and reminded investors to pay attention to risks.